首页> 中文期刊> 《中国卫生标准管理》 >脑梗死患者血清同型半胱氨酸检测结果的临床分析

脑梗死患者血清同型半胱氨酸检测结果的临床分析

         

摘要

Objective To investigate the detection results of serum homocysteine in patients with cerebral infarction.Methods 157 cases of cerebral infarction treated in our hospital from January 2015 to January 2016 were selected as the treatment group. Control group for healthy people over the same period were 140 cases,on serum homocysteine levels were measured and comparison of measurement results. Results In the treatment group,there were 42 cases of high homocysteine,21 cases of the control group with high homocysteine,the difference between the two groups was statisticaly significant, P<0.05. Plasma homocysteine levels in the treatment group were significantly lower than that of the plasma homocysteine levels in patients with recurrent cerebral infarction,the two had significant statistical difference,P<0.05.ConclusionHomocysteine and cerebral infarction has significant correlation,clinical treatment should be effective to prevent patients with high homocysteine,reduce the incidence and recurrence rate of cerebral infarction.%目的:探讨脑梗死患者血清同型半胱氨酸的检测结果。方法选取我院2015年1月~2016年1月收治的157例脑梗死患者作为治疗组。对照组为同期的健康体检者140例,对血清同型半胱氨酸的水平进行测定,分析对比测定结果。结果治疗组中有42例高同型半胱氨酸血症,对照组中有21例高同型半胱氨酸血症,两组差异具有统计学意义,P<0.05。治疗组中首发脑梗死患者的血清同型半胱氨酸水平低于再发脑梗死患者的血清同型半胱氨酸水平,差异具有统计学意义,P<0.05。结论高同型半胱氨酸与脑梗死具有相关性,临床治疗时要有效预防患者出现高同型半胱氨酸血症,降低脑梗死发病率和复发率。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号